Vimarsana
Biggest News Aggregation in the World

Page 23 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

FSSAI warns HP nutraceutical firms launches drive to curb menace of spurious products - Vimarsana News

FSSAI warns HP nutraceutical firms launches drive to curb menace of spurious products

(This story has not been edited by THE WEEK and is auto-generated from a PTI

Source: theweek.in
Omicron: Drug controller gives emergency-use approval to booster vaccine for Omicron variant | India News - Vimarsana News

Omicron: Drug controller gives emergency-use approval to booster vaccine for Omicron variant | India News

India News: NEW DELHI: India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Gennova Bi.

Drug controller's nod for Omicron-specific mRNA-based vaccine - Vimarsana News

Drug controller's nod for Omicron-specific mRNA-based vaccine

India's drug controller has granted emergency use authorisation for the Omicron-specific mRNA-based booster vaccine developed by Genova.

Source: siasat.com
Omicron specific mRNA-based booster vaccine developed in India-Xinhua - Vimarsana News

Omicron specific mRNA-based booster vaccine developed in India-Xinhua

Omicron specific mRNA-based booster vaccine developed in India-

Global Immunomodulators Devices Market to Grow at a Notable CAGR of 5.19% by 2028, Estimates DelveInsight | Petrovax, Acrotech, Astellas, Merck, Biocon, Zydus, Roche, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Horizon Therapeutics, Sun Pharmaceutical, Teva Pharmaceuticals | - Vimarsana News

Global Immunomodulators Devices Market to Grow at a Notable CAGR of 5.19% by 2028, Estimates DelveInsight | Petrovax, Acrotech, Astellas, Merck, Biocon, Zydus, Roche, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Horizon Therapeutics, Sun Pharmaceutical, Teva Pharmaceuticals |

As per DelveInsight, the global Immunomodulators market is estimated to grow at a CAGR of 5.19% during the forecast period from 2023 to 2028. The rising